2型糖尿病
胰岛素抵抗
内科学
静载荷
内分泌学
医学
糖尿病
胰岛素
2型糖尿病
营养物
肥胖
代谢综合征
生物
葡萄糖钳夹技术
同种异体
作者
Marc Prentki,Christopher James Nolan,David Ernest James,Bernard Thorens,Christopher J. Rhodes,Barbara E. Corkey,Charlotte Ling,Philippe Froguel,Chantal Mathieu,Jean–François Gautier,Marc Yves Donath
出处
期刊:Cell Metabolism
[Cell Press]
日期:2026-07-07
卷期号:38 (8): 1540-1556
被引量:8
标识
DOI:10.1016/j.cmet.2026.06.012
摘要
Obesity-related type 2 diabetes (T2D) is currently defined by insulin resistance and impaired insulin secretion. Sulfonylureas, thiazolinediones, and insulin are effective at lowering glycemia yet have not consistently translated into improved long-term outcomes. In contrast, recent interventions often produce metabolic benefits that exceed expectations based on glucose lowering alone. These contrasting observations suggest that our understanding of T2D pathophysiology is incomplete. We propose that, in obesity-related prediabetes and early T2D, insulin resistance, attenuated glucose-stimulated insulin secretion, modest hyperglycemia, and glucosuria represent beneficial functional changes in response to nutrient excess. These allostatic adaptive responses limit glucose flux into metabolically vulnerable tissues and reduce nutrient stress (nutri-stress). From this perspective, T2D is not simply a failure of glucose regulation but a coordinated systemic allostatic response to chronic energy excess aimed at preserving metabolic homeostasis. Therapeutic success may depend not only on lowering glycemia but also on how interventions alter tissue-specific glucose handling and metabolic stress.
科研通智能强力驱动
Strongly Powered by AbleSci AI